Both in Pharmaceuticals
Alaunos Therapeutics vs Onconetix
Over the past year TCRT returned −15.2% and ONCO returned −99.7%; their daily moves had a correlation of -0.02.
TCRT −15.2% ONCO −99.7%Growth of $1, one year, split-adjusted
| Metric | TCRT | ONCO |
|---|---|---|
| Price | $2.63 | $0.4788 |
| Market cap | $6.7M | $2.5M |
| Today | +20.64% | −12.63% |
| 1 month | +64.4% | −27.8% |
| 6 months | −9.9% | −93.5% |
| Year to date | −18.6% | −99.4% |
| 1 year | −17.6% | −99.7% |
| Revenue growth (YoY) | — | −83.9% |
| Gross margin | — | 25.1% |
| Net margin | — | −16748.3% |
| P/E (TTM) | — | — |
| Price / sales | 2,227.2× | 3.9× |
| Net cash | $124.0K | $5.8M |
| Dividend yield | — | — |
| Volatility (60d) | 261.2% | 150.4% |
| Short % of float | 0.1% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).